|
1
|
Dolecek TA, Propp JM, Stroup NE and
Kruchko C: CBTRUS statistical report: Primary brain and central
nervous system tumors diagnosed in the United States in 2005–2009.
Neuro-oncol. 14 Suppl 5:v1–v49. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Korfel A, Thiel E, Martus P, Möhle R,
Griesinger F, Rauch M, Röth A, Hertenstein B, Fischer T,
Hundsberger T, et al: Randomized phase III study of whole-brain
radiotherapy for primary CNS lymphoma. Neurology. 84:1242–1248.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hoang-Xuan K, Bessell E, Bromberg J,
Hottinger AF, Preusser M, Rudà R, Schlegel U, Siegal T, Soussain C,
Abacioglu U, et al: European Association for Neuro-Oncology Task
Force on Primary CNS Lymphoma: Diagnosis and treatment of primary
CNS lymphoma in immunocompetent patients: Guidelines from the
European Association for Neuro-Oncology. Lancet Oncol.
16:e322–e332. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferreri AJ, Cwynarski K, Pulczynski E,
Ponzoni M, Deckert M, Politi LS, Torri V, Fox CP, Rosée PL, Schorb
E, et al: International Extranodal Lymphoma Study Group (IELSG):
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and
rituximab (MATRix regimen) in patients with primary CNS lymphoma:
Results of the first randomisation of the International Extranodal
Lymphoma Study Group-32 (IELSG32) phase 2 trial. Lancet Haematol.
3:e217–e227. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nayak L, Pentsova E and Batchelor TT:
Primary CNS lymphoma and neurologic complications of hematologic
malignancies. Continuum (Minneap Minn). 21:355–372. 2015.PubMed/NCBI
|
|
6
|
Omuro A, Correa DD, DeAngelis LM,
Moskowitz CH, Matasar MJ, Kaley TJ, Gavrilovic IT, Nolan C,
Pentsova E, Grommes CC, et al: R-MPV followed by high-dose
chemotherapy with TBC and autologous stem-cell transplant for newly
diagnosed primary CNS lymphoma. Blood. 125:1403–1410. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Touitou V, LeHoang P and Bodaghi B:
Primary CNS lymphoma. Curr Opin Ophthalmol. 26:526–533. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Houillier C, Choquet S, Touitou V,
Martin-Duverneuil N, Navarro S, Mokhtari K, Soussain C and
Hoang-Xuan K: Lenalidomide monotherapy as salvage treatment for
recurrent primary CNS lymphoma. Neurology. 84:325–326. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Omuro A, Chinot O, Taillandier L,
Ghesquieres H, Soussain C, Delwail V, Lamy T, Gressin R, Choquet S,
Soubeyran P, et al: Methotrexate and temozolomide versus
methotrexate, procarbazine, vincristine, and cytarabine for primary
CNS lymphoma in an elderly population: An intergroup ANOCEF-GOELAMS
randomised phase 2 trial. Lancet Haematol. 2:e251–e259. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vater I, Montesinos-Rongen M, Schlesner M,
Haake A, Purschke F, Sprute R, Mettenmeyer N, Nazzal I, Nagel I,
Gutwein J, et al: The mutational pattern of primary lymphoma of the
central nervous system determined by whole-exome sequencing.
Leukemia. 29:677–685. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yahalom J, Illidge T, Specht L, Hoppe RT,
Li YX, Tsang R and Wirth A: International Lymphoma Radiation
Oncology Group: Modern radiation therapy for extranodal lymphomas:
Field and dose guidelines from the International Lymphoma Radiation
Oncology Group. Int J Radiat Oncol Biol Phys. 92:11–31. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang S, Yu H, Wang X, Lu S, Li Y, Feng L,
Zhang Y, Heo HY, Lee DH, Zhou J, et al: Molecular MRI
differentiation between primary central nervous system lymphomas
and high-grade gliomas using endogenous protein-based amide proton
transfer MR imaging at 3 Tesla. Eur Radiol. 26:64–71. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamada S, Ishida Y, Matsuno A and Yamazaki
K: Primary diffuse large B-cell lymphomas of central nervous system
exhibit remarkably high prevalence of oncogenic MYD88 and CD79B
mutations. Leuk Lymphoma. 56:2141–2145. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kasenda B, Loeffler J, Illerhaus G,
Ferreri AJ, Rubenstein J and Batchelor TT: The role of whole brain
radiation in primary CNS lymphoma. Blood. 128:32–36. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Montesinos-Rongen M, Purschke FG, Brunn A,
May C, Nordhoff E, Marcus K and Deckert M: Primary central nervous
system (CNS) lymphoma B cell receptors recognize CNS proteins. J
Immunol. 195:1312–1319. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mabray MC, Cohen BA, Villanueva-Meyer JE,
Valles FE, Barajas RF, Rubenstein JL and Cha S: Performance of
apparent diffusion coefficient values and conventional MRI features
in differentiating tumefactive demyelinating lesions from primary
brain neoplasms. AJR Am J Roentgenol. 205:1075–1085. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kasenda B, Ferreri AJ, Marturano E, Forst
D, Bromberg J, Ghesquieres H, Ferlay C, Blay JY, Hoang-Xuan K,
Pulczynski EJ, et al: First-line treatment and outcome of elderly
patients with primary central nervous system lymphoma (PCNSL) - a
systematic review and individual patient data meta-analysis. Ann
Oncol. 26:1305–1313. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Welch MR, Sauter CS, Matasar MJ, Faivre G,
Weaver SA, Moskowitz CH and Omuro AM: Autologous stem cell
transplant in recurrent or refractory primary or secondary central
nervous system lymphoma using thiotepa, busulfan and
cyclophosphamide. Leuk Lymphoma. 56:361–367. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Patrick LB and Mohile NA: Advances in
primary central nervous System lymphoma. Curr Oncol Rep. 17:602015.
View Article : Google Scholar : PubMed/NCBI
|
